Aleris has sold its primary care operations to Lideta Hälsovård AB
As part of the ongoing strategic effort to specialize its Swedish healthcare business, Aleris divests its primary care business to Lideta Hälsovård AB (Lideta), a subsidiary of Nordstjernan.
Aleris is one of Scandinavia’s leading private and healthcare service providers, offering a wide range of services, including primary and specialist care, diagnostics, elderly, and psychiatric care for youth and adults. Aleris Primary Care consist of eleven of Aleris’ units providing care services within primary care and physical therapy for some 110,000 listed patients in Stockholm and Uppsala regions.
Lideta is a healthcare company within primary, maternity and child care as well as occupational healthcare in Stockholm and southern Sweden. Nordstjernan is its main owner and has the ambition to build a long-term, high-quality Swedish care provider. Lideta includes the healthcare group Mama Mia, Scandinavia's single largest private maternity care center located in Stockholm and Skåne. Mama Mia's activities also include gynecology, contraception counseling, ultrasound, as well as child and adolescent medical practices.
Patricia Industries is responsible for the wholly owned subsidiaries of Investor AB. Patricia Industries builds and develops companies with long-term growth potential in the Nordics and North America with strong customer relationships, brands and organizations.
Oaklins’ team in Sweden advised the seller in this carve-out divestment. The deal is another example of Oaklins Sweden’s strong presence within the local healthcare market.
Prata med transaktionsteamet
Relaterade transaktioner
Instituto Sanitas and Chemopharma have been acquired by Laboratorios Saval
Instituto Sanitas and Chemopharma, leading pharmaceutical laboratories in Chile, have been acquired by Laboratorios Saval S.A., a prominent pharmaceutical company based in Chile with a regional presence across Latin America. The transaction strengthens Laboratorios Saval’s growth strategy and supports its expansion in the affordable medicines segment.
Lär dig merRare Patient Voice has been acquired by Konovo
Rare Patient Voice has been acquired by Konovo, a technology-first healthcare intelligence company backed by Fraser Healthcare Partners.
Lär dig merLindenhofgruppe has sold its majority stake in LabPoint to Affidea Switzerland
LabPoint Medical Laboratories AG has been acquired by Affidea Switzerland AG. Through the transaction, Lindenhofgruppe AG gains a strong strategic partner to support the further development of LabPoint and will remain a shareholder with a reduced stake, continuing as a key customer of the company. It lays the foundation for LabPoint’s sustainable development under a new anchor shareholder, with the aim of further strengthening and selectively expanding its position in laboratory diagnostics.
Lär dig mer